67.6% women) who were randomly assigned to receive subcutaneous cagrilintide/semaglutide (CagriSema, Novo Nordisk), semaglutide 2.4 mg alone (Wegovy, Novo Nordisk), cagrilintide 2.4 mg alone or placebo
Direct access to your doctor throughout the protocol for questions, adjustments and check-ins
It helps with DNA production, fatty acid synthesis, and energy
Every user is entitled to the following: The right to access You have the right to request copies of your personal data
For personalized protocol recommendations, take the Peptide Quiz
No commercial ties We dont sell, supply, or link to suppliers of any medicine, and arent affiliated with any manufacturer